NEW YORK (GenomeWeb News) – Canadian molecular diagnostics firm GeneNews has proposed a private placement of its common shares that would bring in proceeds of C$2 million (US$1.9 million).

The firm is planning to place 4,444,444 common shares at a price of $.45 per share. It said that an unidentified labor-sponsored investment fund will subscribe for half of those shares at a total price of C$1 million, with the remainder of the shares being purchased by "arm's length parties."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.